Phase 1

Early-phase trials are complex and come with their own set of scientific and operational challenges. TKL Research is committed to executing your study efficiently without sacrificing quality. Our experience and expertise have allowed us to develop a comprehensive approach to fully support your study from start to finish.

Clinical Pharmacology

TKL’s clinical pharmacology units are dedicated to the conduct of early phase studies in healthy and patient populations. We offer fluid floor plans giving us the ability to adapt our facility to meet the needs of the most demanding study. From protocol development to final clinical study report delivery, our skilled staff is ready to bring your study to life.

  • 40 Bed Phase I Pharmacology Unit
  • Configurable Male/Female Dormitories
  • Centralized Nursing Station
  • Infusion Wards
  • Pharmacy
  • Comprehensive Clinical Laboratory
  • Dedicated Photobiology Room
  • Multiple Outpatient Examination Rooms
  • Diverse Volunteer Population
  • Access to the 3 NY Metro Area Airports
  • Accessible to NY/NJ Medical Community

“Our management averages over 20 years of experience in the clinical research community.”

~ Gregory Anderson – VP Business Development – TKL Research

Early Development Experience

  • First In Human (FIH) – safety/tolerance
  • Drug to Drug Interaction (DDI)
  • Food Effect
  • Single Ascending Dose (SAD)
  • Multiple Ascending Dose (MAD)
  • Bioequivalence/Bioavailability (BE/BA)
  • Proof of Concept
  • Maximal Use
  • Dose Ranging (topicals)
  • Systemic Photosensitivity PK
  • HAL/ADF Category 2 & 3

Drug-Induced Photosensitivity

As the experts in dermatology, we have you covered when it comes to evaluating the photosensitivity potential of systemic agents. Our proficiency in early phase work and photosensitivity testing as well our groundbreaking study designs insure a successful study.

A niche we know well, we invite you to read over our methodology on a new comprehensive study design to test photosensitization potential which was approved and accepted by the FDA.

Our longevity is priceless. Our expertise is rare. Our turnkey approach is unrivaled.

TKL Research is not your average CRO.